CURRENT AFFAIRS

Detailed explanation-1: -Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.

Detailed explanation-2: -Since 2017, six CAR T-cell therapies have been approved by the Food and Drug Administration (FDA). All are approved for the treatment of blood cancers, including lymphomas, some forms of leukemia, and, most recently, multiple myeloma.

Detailed explanation-3: -What Is CAR T Cell Therapy? CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.

Detailed explanation-4: -As such, chimeric antigen receptor (CAR) T cell therapy represents an emerging therapeutic option for pancreatic cancer. This modality utilizes genetically engineered T cells that are redirected to specific cancer-associated antigens to elicit potent cytotoxic activity.

Detailed explanation-5: -Today, CAR T cell therapy is approved by the Food and Drug Administration (FDA) to treat certain types of leukemia, lymphoma, and most recently, myeloma. The treatment has produced dramatic results for many patients. In some cases, it has eliminated all evidence of cancer.